SCNX

Scienture Holdings, Inc. Common Stock NASDAQ Listed Feb 22, 2008

Healthcare ·Pharmaceutical Preparations · scienture.com

$0.42

Mkt Cap $6.5M

usd

52w Low $0.24 7.9% of range 52w High $2.60

50d MA $0.40 200d MA $0.75

P/E (TTM) -0.1x

EV/EBITDA —

P/B 0.2x

Debt/Equity 0.0x

ROE -59.2%

P/FCF —

RSI (14) —

ATR (14) —

Beta —

50d MA $0.40

200d MA $0.75

Avg Volume —

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

SIC Code

2834

CIK (SEC)

1382574

Phone

(800) 261 0281

20 AUSTIN BLVD. · COMMACK, NY 11725

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 24, 2026	AMC	-0.22	-1.76	-700.0%	0.46	+0.9%	-0.3%	-1.3%	-7.8%	-42.2%	+18.3%	—
Nov 12, 2025	AMC	—	-0.19	—	0.71	+2.7%	-5.5%	-4.3%	-8.7%	+6.9%	-6.8%	—
Aug 12, 2025	AMC	—	-0.48	—	2.09	+0.5%	+6.2%	-45.5%	+0.0%	-2.5%	-5.1%	—
May 12, 2025	AMC	—	-0.33	—	0.94	-1.1%	-4.8%	+1.6%	-1.0%	-1.0%	+6.5%	—
Mar 26, 2025	AMC	—	-0.82	—	1.71	-0.6%	-3.5%	-6.1%	-7.1%	-6.9%	-7.5%	—
Nov 6, 2024	AMC	-0.15	-1.34	-793.3%	8.06	+1.7%	+0.9%	-2.3%	+2.1%	+3.5%	-3.0%	—
Aug 9, 2024	AMC	-0.15	-1.04	-593.3%	—	—	—	—	—	—	—	—
Jun 26, 2024	AMC	-0.15	-6.40	-4166.7%	—	—	—	—	—	—	—	—
Dec 31, 2023	AMC	—	-4.93	—	—	—	—	—	—	—	—	—
Sep 30, 2023	AMC	-0.15	-1.49	-894.5%	—	—	—	—	—	—	—	—
Jun 30, 2023	AMC	-0.75	-2.90	-286.5%	—	—	—	—	—	—	—	—
Mar 31, 2023	AMC	-0.30	-1.01	-236.9%	—	—	—	—	—	—	—	—

Data updated apr 27, 2026 12:27am · Source: massive.com